San Rafael based BioCision will be showcasing their new ThawSTAR® CB Cryobag Thawing System at the International Society for Cellular Therapy (ISCT) 2016 annual meeting in Singapore at the end of May.
“The ThawSTAR CB System is a novel instrument that automates, and most importantly, de-risks bag thawing from manufacturing to point-of-care,” said Rolf O. Ehrhardt, MD, PhD, BioCision CEO. “Until recently, controlled thawing of a vial or bag was a frequently overlooked step in the cold chain. The ThawSTAR system allows our customers to improve the overall handling of cell therapies and further standardize this critical ‘last mile’ process.”
BioCision will be exhibiting at booth B19 during ISCT, May 25-28.
Fore more information, visit the BioCision website.